Aktiespot

Mangoceuticals, Inc. Aktie

MGRX

Geschlossen
$0.3570-0.0323 (-8.30%)
Chart wird geladen...
Mangoceuticals, Inc. Logo

Mangoceuticals, Inc.

Eröffnung0.3900
Hoch0.3951
Tief0.3449
Volumen360.42k
P/EN/A
Marktkapitalisierung6.13M
52-Wochen-Hoch2.7500
52-Wochen-Tief0.1620
Durchschn. Volumen6.53M
DividendeN/A
Beta2.27
EPS-1.2700

Über Mangoceuticals, Inc. Aktie

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. In addition, the company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Unternehmensinformationen

Börse: NasdaqCM (NCM)
Sektor: Sundhed
Branche: Sundhedsinformationstjenester
Adresse:
17130 N. Dallas Parkway
75248 Dallas, United States
Telefon: + 214 242 9619

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: